Recipient of federal assistance · CHANDLER, AZ
IMMUNOSHIELD THERAPEUTICS INC.
IMMUNOSHIELD THERAPEUTICS INC. received $935.2K in federal grants and other assistance in FY2026, on 3 actions, +2.3% vs FY2025. It has no federal contracts in the loaded years. Since FY2023: $2.1M. Its largest awarding agency was National Institutes of Health ($935.2K).
- Assistance · FY2026
- $935.2K
- New awards
- 0
- Actions
- 3
- Since FY2023
- $2.1M
- UEI
- F4L8SL24M5D5
- Location
- CHANDLER, AZ
Businesses
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
Assistance by fiscal year
- 298.4KFY2023
- 913.9KFY2025
- 935.2KFY2026
By type
- Grants$935.2K100%
Top programs · Awarding agencies
Obligations in FY2026.
Top programs
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$935.2K100%
Awarding agencies
- National Institutes of Health$935.2K100%Department of Health and Human Services
Largest awards
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 3, 2025 – Jul 30, 2026· R44DK136496
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Aug 4, 2023 – Mar 23, 2026· R43DK136496
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2023–FY2026.